Timothy M Ring $BDX SEC Form 4 Insider Trading

Timothy M Ring has filed a total of 0 insider trades in $BDX since 2021. Their most recent trade was a of shares, made on . Their largest trade was a of shares, made on . We estimate that they now own 158,193 shares of $BDX, worth an estimated $29.0 million.

Insider Trading at $BDX

There have been a total of 66 insider trades reported at $BDX since 2021, with 6,750 shares purchased and 99,740 shares sold. The most active insider traders in $BDX stock have been Betty D Larson, Roland Goette, and Michael David Garrison. The most recent trade was a sale of 629 shares reported by Michael David Garrison (EVP & Pres Med.Essntl&BioPharm), made on Dec 17, 2025.

$BDX Executives and Stock Owners with Insider Trades

• Betty D Larson, EVP HR & CHRO

• Roland Goette, EVP and President EMEA

• Michael David Garrison, EVP & President, Medical

• Richard Byrd, EVP & President Interventional

• Thomas J Spoerel, VP Controller & Chief Acct Off

• David Hickey, EVP & President, Life Sciences

• David Shan, EVP and Chief ISC Officer

• Michael David Garrison, EVP & President Medical

• Michael Feld, EVP & President, Life Sciences

• Shana Carol Neal, EVP and Chief People Officer

• Thomas J Spoerel, SVP,Controller&Chief Acct Off

• Roland Goette, EVP and President, EMEA

• Samrat S. Khichi, EVP and General Counsel

• Thomas E Jr Polen, Chairman, CEO and President

• Thomas E Jr Polen, Executive Vice President

• Alexandre Conroy, EVP of Integrated Supply Chain

• Michael David Garrison, EVP & Pres Med.Essntl&BioPharm

• James C Lim, Executive Vice President

• Michael Feld, EVP, CRO & Pres. Life Sciences

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.